While the research on prostate cancer is extensive, this research does not estimate an overall cost, considering all the direct (e.g., appointments and medication) and indirect (e.g., dealing with complications) costs associated with treatments of prostate cancer considering different risk levels ...
Comparing the Effects of Different Prostate Cancer Treatments on Quality of Life and Cancer Recurrence—NC ProCESSdoi:10.25302/09.2020.cer.131006453... RC Chen,R Basak,A Katz 被引量: 0发表: 2020年 Review of the Different Treatments and Management for Prostate Cancer and Fertility OBJECTIVE To com...
(HealthDay)—Most patients with localized prostate cancer know little about the out-of-pocket expenses (OOPE) of the different treatments, and would not have chosen a different treatment even if they had known the actual OOPE of their treatment, according to a study published in the December ...
aFor example, there are a variety of treatments for prostate cancer, with wide variations in costs but no clear evidence of superiority for one type of treatment over another (Leonhardt, 2009). 例如,有各种各样的治疗为摄护腺癌,以变化繁多在费用,但没有优势的清楚的证据为一种治疗方式在另一 (...
Analysis of treatment pattern according to age group revealed an increased proportion of surgery in all age groups, particularly in patients over 75 years of age (Fig. 1). Table 2 Trends in national practice patterns of prostate cancer in Korea from 2005 to 2014 Full size table Fig. 1 ...
Sixty-four percent of T2 resources were used in primary sector and 11% at inpatient admissions, which was the highest percentage among the treatment regimes. T4 patients generally used more resources in the hospital sector compared to the other surgical treatments (T2 and T3). Table 2 Total ...
Adverse event (AE)-related costs represent an important component of economic models for cancer care. However, since previous studies mostly focused on specific AEs, treatments, or cancer types, limited information is currently available. Therefore, this study assessed the incremental healthcare costs ...
Economic Benefits of Aggressive Lipid Lowering: A Managed Care PerspectiveRelated Videos Full Video Abstract: Evidence for Oral Semaglutide in Type 2 Diabetes Related Content Publications September 20th 2024 Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Trea...
Of the 7 commonly used treatments PDE-5 inhibitor therapy had the lowest annual cost per user.Section snippets Study design and data sources A retrospective cohort study design was used in our study. The cohort included all managed care health plan members 18 years or older who had an ED ...
Hans Christian Andersen and the value of new cancer treatments. J Natl Cancer Inst. 2018;110(5):441-442. doi:10.1093/jnci/djx261 PubMedGoogle ScholarCrossref 74. Cherny NI. An appraisal of FDA approvals for adult solid tumours in 2017-2021: has the eagle landed? Nat...